DermTech’s Pigmented Lesion Assay Could Detect Melanoma at Its Earliest Stages, TRUST Study Suggests
Results of DermTech Inc's TRUST study were published recently in SKIN: The Journal Of Cutaneous Medicine, the company announces.
Results of DermTech Inc's TRUST study were published recently in SKIN: The Journal Of Cutaneous Medicine, the company announces.
Patients who received Botox before corrective jaw surgery reported less pain and used fewer opioids during recovery than those given a placebo.
The product is the first botulinum toxin type E approved for aesthetic use and is designed to deliver faster onset and shorter-lasting results than traditional neurotoxins.
Applications are now being accepted for the 2026–2027 American Board of Medical Specialties Scholars Program.
Read MoreAllergan Aesthetics presented new research at AMWC 2026 indicating a shift toward subtle, natural-looking outcomes in hyaluronic acid injectables and emphasizing the role of personalized treatment approaches.
Read MoreNew framework aims to address inconsistencies in how skin quality is described during aesthetic consultations.
Read MoreAn analysis of national search trends and surgeon workforce data highlights rising patient interest in aesthetic procedures across Southern, Midwestern, and rural regions where access to board-certified plastic surgeons remains limited.
Read MorePhase 4 study data presented at the American Academy of Pain Medicine PainConnect 2026 meeting reported that more than 90% of patients undergoing aesthetic or reconstructive procedures remained opioid-free when treated with Journavx as part of multimodal pain therapy.
Read MoreResearchers found participation among underrepresented racial and ethnic groups increased far beyond national population growth.
Read MoreA national survey shows how GLP-1–associated weight loss is driving facial volume loss, laxity, and wrinkles—and why fillers and neuromodulators anchor treatment for this growing patient group. Plastic Surgery Practice talks to one of the study’s authors to break down the findings and what they mean for treatment planning in today’s aesthetic practice.
Read MoreA principal investigator discusses new randomized, controlled data on VYC-12L, a hyaluronic acid injectable, studied for reducing transverse neck lines and improving overall neck appearance, with implications for non-surgical neck rejuvenation in aesthetic practice.
Read MoreTwo new clinical analyses examine how simultaneous, on-label 64-unit onabotulinumtoxinA treatment of the upper face delivers natural-looking, durable, and predictable outcomes across diverse patient populations and multiple treatment cycles.
Read MoreA machine learning model analyzed data from more than 700 procedures and predicted intraoperative blood loss with 94% accuracy
Read MoreA study finds patients with a history of COVID had higher rates of venous thromboembolism following panniculectomy, even with standard clot prevention.
Read MoreBrian Pilcher, PhD, discusses Conexeu’s CXU platform and what 3D-printed extracellular matrix technology could mean for future reconstructive and aesthetic surgery.
Read MoreThe research team trained the system on more than 33,000 dermoscopic images paired with clinical metadata.
Read MoreConexeu Sciences has produced the first 3D-printed collagen-based extracellular matrix using its CXU platform, signaling a potential shift in regenerative medicine.
Read MoreThe multicenter trial showed the combination therapy offered superior efficacy, rapid repigmentation, and a strong safety profile compared to monotherapy.
Read More